<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Bloomage Passes GMP Audit by South Korea&#039;s MFDS, Strengthening its Global Quality Assurance</title>
    <link>https://www.taxtmi.com/news?id=37751</link>
    <description>Bloomage passed an on-site Good Manufacturing Practices (GMP) inspection with no non-compliance observations after evaluation of six core systems: quality management, material management, production management, equipment and facilities, packaging and labeling, and laboratory control. The inspecting authority&#039;s membership in PIC/S reflects international GMP harmonization. Meeting these standards enables Bloomage to supply GMP-certified pharmaceutical-grade Sodium Hyaluronate to Korean pharmaceutical manufacturers across ophthalmology, orthopedics, aesthetic medicine, regenerative medicine and other regulated product categories.</description>
    <language>en-us</language>
    <pubDate>Wed, 19 Mar 2025 10:31:02 +0530</pubDate>
    <lastBuildDate>Wed, 19 Mar 2025 10:31:03 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=807392" rel="self" type="application/rss+xml"/>
    <item>
      <title>Bloomage Passes GMP Audit by South Korea&#039;s MFDS, Strengthening its Global Quality Assurance</title>
      <link>https://www.taxtmi.com/news?id=37751</link>
      <description>Bloomage passed an on-site Good Manufacturing Practices (GMP) inspection with no non-compliance observations after evaluation of six core systems: quality management, material management, production management, equipment and facilities, packaging and labeling, and laboratory control. The inspecting authority&#039;s membership in PIC/S reflects international GMP harmonization. Meeting these standards enables Bloomage to supply GMP-certified pharmaceutical-grade Sodium Hyaluronate to Korean pharmaceutical manufacturers across ophthalmology, orthopedics, aesthetic medicine, regenerative medicine and other regulated product categories.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Wed, 19 Mar 2025 10:31:02 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=37751</guid>
    </item>
  </channel>
</rss>